CHRNA3 and Cognitive impairment: Despite cardiotoxic side effects preventing the approval of several α7nAChR agonists, nicotine-derived agonistic compounds like cytisine, which increase Chrna3 expression, appear promising for cognitive function and neurological disease-related cognitive impairment.